Health authorities say they are continuing to manage the shortage and supply of IV fluids as a priority. Doctors are fighting ...

Otsuka Holdings will pay ICU Medical an upfront payment of $200 million. The U.S. IV products market has seen ...

U.S. hospitals are experiencing a shortage of IV fluids, triggered by a disruption at Baxter's North Carolina plant following Hurricane Helene. As hospitals have scrambled to conserve supplies, at ...

When Hurricane Milton barreled through the Gulf of Mexico with a ferocity that brought one Florida-based meteorologist to tears, Beth Gore’s biggest worry wasn’t ...

As the nation’s largest supplier of intravenous fluids works to return to full production in North Carolina, Self Regional ...

Also known as a polymyxin B haemoperfusion (PMX), Toraymyxin is a haemoperfusion device that removes endotoxin, a toxic ...

Baxter International warned on Friday that hurricane-related disruptions at its North Carolina IV solutions facility could affect its financials through early 2025. Shares of the medical products ...

A recent shortage of intravenous solutions underscores the need to address the fragile supply chain for infusion therapy ...

The company, which is a key producer for American healthcare providers, was hit by the hurricane when it tore through western ...

Baxter expects to restart a second IV solutions manufacturing line within the next week, the company announced Nov. 7. Along ...

Hospitals in the region are grappling with an ongoing shortage of IV fluids, a situation exacerbated by hurricane damage.